BC
AUTL

BIT Capital’s Autolus Therapeutics AUTL Stock Holding History

BIT Capital’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-199,359
Closed -$309K – 95
2025
Q1 		$309K Sell
199,359
-437,620
-69% -$888K 0.03% 88
2024
Q4 		$1.5M Buy
636,979
+379,050
+147% +$1.28M 0.12% 62
2024
Q3 		$936K Buy
257,929
+82,942
+47% +$331K 0.09% 73
2024
Q2 		$609K Sell
174,987
-34,491
-16% -$149K 0.05% 95
2024
Q1 		$1.34M Buy
209,478
+179,415
+597% +$1.12M 0.1% 79
2023
Q4 		$194K Buy
+30,063
New +$115K 0.02% 73

Other funds holding AUTL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

BIT Capital's AUTL Position: Q2 2025 in Review

BIT Capital sold out of Autolus Therapeutics (AUTL) in Q2 2025, closing a stake of 199,359 shares — an estimated $309K sold.

BIT Capital first reported a position in AUTL in Q4 2023 and held it in 6 quarters. The position peaked at $1.5M in Q4 2024. 94 funds tracked by Wall St. Rank hold AUTL as of Q2 2025.

  • BIT Capital reported no remaining Autolus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • BIT Capital sold 199,359 Autolus Therapeutics shares in Q2 2025, an estimated $309K.
  • BIT Capital first reported a position in Autolus Therapeutics in Q4 2023 and held it in 6 quarters.
  • BIT Capital's Autolus Therapeutics position peaked at $1.5M in Q4 2024.
  • 94 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2025.

Based on BIT Capital's 13F filing for Q2 2025, filed 8 Aug 2025.